Phase 1 study of OPB-31121 in patients with relapsed or refractory non-Hodgkin's lymphoma or multiple myeloma
Phase of Trial: Phase I
Latest Information Update: 27 Feb 2017
At a glance
- Drugs OPB 31121 (Primary)
- Indications Multiple myeloma; Non-Hodgkin's lymphoma
- Focus Adverse reactions
- 31 Jan 2008 Status changed from initiated to recruiting.
- 23 Aug 2007 New trial record.